Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX.DL)

CAPS Rating: No stars

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

1
Player Avatar withoutlimits (83.61) Submitted: 12/12/2007 3:10:27 PM : Underperform Start Price: $55.53 ONXX.DL Score: -111.01

I think it has exceed a reasonable price in the short term.

Featured Broker Partners


Advertisement